[1]AhrendsT, SpanjaardA, PilzeckerB, et al., 2017. CD4⁺ T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity, 47(5):848-861.e5.

[2]AllenCDC, OkadaT, TangHL, et al., 2007. Imaging of germinal center selection events during affinity maturation. Science, 315(5811):528-531.

[3]AllenE, JabouilleA, RiveraLB, et al., 2017. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med, 9(385):eaak9679.

[4]AloisiF, Pujol-BorrellR, 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol, 6(3):205-217.

[5]AmariaRN, ReddySM, TawbiHA, et al., 2018. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med, 24(11):1649-1654.

[6]AnselKM, NgoVN, HymanPL, et al., 2000. A chemokine-driven positive feedback loop organizes lymphoid fol

[7]licles. Nature, 406(6793):309-314.

[8]AsrirA, TardiveauC, CoudertJ, et al., 2022. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell, 40(3):318-334.e9.

[9]BaroneF, GardnerDH, NayarS, et al., 2016. Stromal fibroblasts in tertiary lymphoid structures: a novel target in chronic inflammation. Front Immunol, 7:477.

[10]BénézechC, WhiteA, MaderE, et al., 2010. Ontogeny of stromal organizer cells during lymph node development. J Immunol, 184(8):4521-4530.

[11]BénézechC, LuuNT, WalkerJA, et al., 2015. Inflammation-induced formation of fat-associated lymphoid clusters. Nat Immunol, 16(8):819-828.

[12]BennettSRM, CarboneFR, KaramalisF, et al., 1997. Induction of a CD8⁺ cytotoxic T lymphocyte response by cross-priming requires cognate CD4⁺ T cell help. J Exp Med, 186(1):65-70.

[13]BerekC, BergerA, ApelM, 1991. Maturation of the immune response in germinal centers. Cell, 67(6):1121-1129.

[14]BindeaG, MlecnikB, TosoliniM, et al., 2013. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity, 39(4):782-795.

[15]BraunA, WorbsT, MoschovakisGL, et al., 2011. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol, 12(9):879-887.

[16]BuisseretL, GaraudS, de WindA, et al., 2017. Tumor-infiltrating lymphocyte composition, organization and PD-1/PD-L1 expression are linked in breast cancer. OncoImmunology, 6(1):e1257452.

[17]CabritaR, LaussM, SannaA, et al., 2020. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature, 577(7791):561-565.

[18]CalderaroJ, PetitprezF, BechtE, et al., 2019. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. J Hepatol, 70(1):58-65.

[19]CarmiY, SpitzerMH, LindeIL, et al., 2015. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature, 521(7550):99-104.

[20]CarregaP, LoiaconoF, di CarloE, et al., 2015. NCR⁺ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun, 6:8280.

[21]CastellinoF, HuangAY, Altan-BonnetG, et al., 2006. Chemokines enhance immunity by guiding naive CD8⁺ T cells to sites of CD4⁺ T cell-dendritic cell interaction. Nature, 440(7086):890-895.

[22]CastinoGF, CorteseN, CaprettiG, et al., 2016. Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. OncoImmunology, 5(4):e1085147.

[23]ChoiYS, KageyamaR, EtoD, et al., 2011. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity, 34(6):932-946.

[24]CilloAR, KurtenCHL, TabibT, et al., 2020. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity, 52(1):183-199.e9.

[25]ColbeckEJ, JonesE, HindleyJP, et al., 2017. Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction. Cancer Immunol Res, 5(11):1005-1015.

[26]CuiC, WangJW, FagerbergE, et al., 2021. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell, 184(25):6101-6118.e13.

[27]DaiSY, ZengH, LiuZP, et al., 2021. Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma. J Immunother Cancer, 9(2):e001823.

[28]DejardinE, DroinNM, DelhaseM, et al., 2002. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity, 17(4):525-535.

[29]DenkertC, von MinckwitzG, Darb-EsfahaniS, et al., 2018. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol, 19(1):40-50.

[30]DepilS, DuchateauP, GruppSA, et al., 2020. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. Nat Rev Drug Discov, 19(3):185-199.

[31]de TogniP, GoellnerJ, RuddleNH, et al., 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science, 264(5159):703-707.

[32]di PucchioT, ChatterjeeB, Smed-SörensenA, et al., 2008. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol, 9(5):551-557.

[33]DraytonDL, LiaoS, MounzerRH, et al., 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol, 7(4):344-353.

[34]EickhoffS, BrewitzA, GernerMY, et al., 2015. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell, 162(6):1322-1337.

[35]FurtadoGC, PacerME, BongersG, et al., 2014. TNFα-dependent development of lymphoid tissue in the absence of RORγt⁺ lymphoid tissue inducer cells. Mucosal Immunol, 7(3):602-614.

[36]GarnerH, deVisser KE, 2020. Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nat Rev Immunol, 20(8):483-497.

[37]GeeMH, HanA, LofgrenSM, et al., 2018. Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes. Cell, 172(3):549-563.e16.

[38]GermainC, GnjaticS, TamzalitF, et al., 2014. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med, 189(7):832-844.

[39]GeurtsvankesselCH, WillartMAM, BergenIM, et al., 2009. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med, 206(11):2339-2349.

[40]GiraldoNA, Sanchez-SalasR, PeskeJD, et al., 2019. The clinical role of the TME in solid cancer. Br J Cancer, 120(1):45-53.

[41]GocJ, GermainC, Vo-BourgaisTKD, et al., 2014. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8⁺ T cells. Cancer Res, 74(3):705-715.

[42]GoenkaR, BarnettLG, SilverJS, et al., 2011. Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultim

[43]ate effector differentiation. J Immunol, 187(3):1091-1095.

[44]GroeneveldCS, FontugneJ, CabelL, et al., 2021. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Eur J Cancer, 148:181-189.

[45]Gu-TrantienC, LoiS, GaraudS, et al., 2013. CD4⁺ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest, 123(7):2873-2892.

[46]GuedjK, Khallou-LaschetJ, ClementM, et al., 2014. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc Res, 101(3):434-443.

[47]GunnMD, NgoVN, AnselKM, et al., 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma receptor-1. Nature, 391(6669):799-803.

[48]HalleS, DujardinHC, BakocevicN, et al., 2009. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med, 206(12):2593-2601.

[49]HeJJ, XiongXX, YangH, et al., 2022. Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response. Cell Res, 32(6):530-542.

[50]HelminkBA, ReddySM, GaoJJ, et al., 2020. B cells and tertiary lymphoid structures promote immunotherapy response. Nature, 577(7791):549-555.

[51]HinshawDC, ShevdeLA, 2019. The tumor microenvironment innately modulates cancer progression. Cancer Res, 79(18):4557-4566.

[52]HiraokaN, InoY, Yamazaki-ItohR, et al., 2015. Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br J Cancer, 112(11):1782-1790.

[53]HodiFS, O'DaySJ, McDermottDF, et al., 2010. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med, 363(8):711-723.

[54]HorJL, WhitneyPG, ZaidA, et al., 2015. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4⁺ and CD8⁺ T cell activation to localized viral infection. Immunity, 43(3):554-565.

[55]JansenCS, ProkhnevskaN, MasterVA, et al., 2019. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature, 576(7787):465-470.

[56]JanssenEM, LemmensEE, WolfeT, et al., 2003. CD4⁺ T cells are required for secondary expansion and memory in CD8⁺ T lymphocytes. Nature, 421(6925):852-856.

[57]JiangXG, 2020. Lymphatic vasculature in tumor metastasis and immunobiology. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(1):3-11.

[58]JinKF, CaoYF, GuY, et al., 2021. Poor clinical outcomes and immunoevasive contexture in CXCL13⁺CD8⁺ T cells enriched gastric cancer patients. OncoImmunology, 10(1):1915560.

[59]Johansson-PercivalA, HeB, LiZJ, et al., 2017. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol, 18(11):1207-1217.

[60]JoshiNS, Akama-GarrenEH, LuYS, et al., 2015. Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses. Immunity, 43(3):579-590.

[61]KatoY, ZaidA, DaveyGM, et al., 2015. Targeting antigen to Clec9A primes follicular Th cell memory responses capable of robust recall. J Immunol, 195(3):1006-1014.

[62]KerfootSM, YaariG, PatelJR, et al., 2011. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity, 34(6):947-960.

[63]KinkerGS, VitielloGAF, FerreiraWAS, et al., 2021. B cell orchestration of anti-tumor immune responses: a matter of cell localization and communication. Front Cell Dev Biol, 9:678127.

[64]KrishnaswamyJK, GowthamanU, ZhangBY, et al., 2017. Migratory CD11b⁺ conventional dendritic cells induce T follicular helper cell-dependent antibody responses. Sci Immunol, 2(18):eaam9169.

[65]KroegerDR, MilneK, NelsonBH, 2016. Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer. Clin Cancer Res, 22(12):3005-3015.

[66]LeeJM, LeeMH, GaronE, et al., 2017. Phase I trial of intratumoral injection of CCL21 gene-modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8⁺ T-cell infiltration. Clin Cancer Res, 23(16):4556-4568.

[67]LeeY, ChinRK, ChristiansenP, et al., 2006. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure. Immunity, 25(3):499-509.

[68]LeiX, LeiY, LiJK, et al., 2020. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett, 470:126-133.

[69]LiHJ, van der LeunAM, YofeI, et al., 2019. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell, 176(4):775-789.e18.

[70]LiJP, WuCY, ChenMY, et al., 2021. PD-1⁺CXCR5^-CD4⁺ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma. J Immunother Cancer, 9(7):e002101.

[71]LochnerM, OhnmachtC, PresleyL, et al., 2011. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγ T and LTi cells. J Exp Med, 208(1):125-134.

[72]LutherSA, LopezT, BaiW, et al., 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity, 12(5):471-481.

[73]LutherSA, BidgolA, HargreavesDC, et al., 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol, 169(1):424-433.

[74]LutherSA, AnselKM, CysterJG, 2003. Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J Exp Med, 197(9):1191-1198.

[75]LutzER, WuAA, BigelowE, et al., 2014. Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol Res, 2(7):616-631.

[76]MaldonadoL, TeagueJE, MorrowMP, et al., 2014. Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med, 6(221):221ra213.

[77]MartinetL, GarridoI, FilleronT, et al., 2011. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res, 71(17):5678-5687.

[78]MatsubaraS, SekiM, SuzukiS, et al., 2019. Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors. J Immunother Cancer, 7(1):256.

[79]MebiusRE, RennertP, WeissmanIL, 1997. Developing lymph nodes collect CD4⁺CD3^-LTβ⁺ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity, 7(4):493-504.

[80]MeylanM, PetitprezF, BechtE, et al., 2022. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity, 55(3):527-541.e5.

[81]MorcretteG, HirschTZ, BadourE, et al., 2019. APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures. OncoImmunology, 8(6):e1583547.

[82]MounzerRH, SvendsenOS, BalukP, et al., 2010. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood, 116(12):2173-2182.

[83]Munoz-ErazoL, RhodesJL, MarionVC, et al., 2020. Tertiary lymphoid structures in cancer—considerations for patient prognosis. Cell Mol Immunol, 17(6):570-575.

[84]NgoVN, KornerH, GunnMD, et al., 1999. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med, 189(2):403-412.

[85]NiogretJ, BergerH, RebeC, et al., 2021. Follicular helper-T cells restore CD8⁺-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy. J Immunother Cancer, 9(6):e002157.

[86]NoëlG, FontsaML, GaraudS, et al., 2021. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J Clin Invest, 131(19): e139905.

[87]Overacre-DelgoffeAE, BumgarnerHJ, CilloAR, et al., 2021. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity, 54(12):2812-2824.e4.

[88]PardollDM, 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer, 12(4):252-264.

[89]PeskeJD, ThompsonED, GemtaL, et al., 2015. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun, 6:7114.

[90]PetersA, PitcherLA, SullivanJM, et al., 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity, 35(6):986-996.

[91]PetitprezF, de ReynièsA, KeungEZ, et al., 2020. B cells are associated with survival and immunotherapy response in sarcoma. Nature, 577(7791):556-560.

[92]PitzalisC, JonesGW, BombardieriM, et al., 2014. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol, 14(7):447-462.

[93]PoschF, SilinaK, LeiblS, et al., 2018. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. OncoImmunology, 7(2):e1378844.

[94]RidgeJP, di RosaF, MatzingerP, 1998. A conditioned dendritic cell can be a temporal bridge between a CD4⁺ T-helper and a T-killer cell. Nature, 393(6684):474-478.

[95]RodriguezAB, PeskeJD, WoodsAN, et al., 2021. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep, 36(3):109422.

[96]RuffinAT, CilloAR, TabibT, et al., 2021. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat Commun, 12:3349.

[97]Sautès-FridmanC, PetitprezF, CalderaroJ, et al., 2019. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer, 19(6):307-325.

[98]SchmittN, MoritaR, BourderyL, et al., 2009. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity, 31(1):158-169.

[99]SchoenbergerSP, ToesREM, van der VoortEIH, et al., 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40‒CD40L interactions. Nature, 393(6684):480-483.

[100]ShalapourS, LinXJ, BastianIN, et al., 2017. Inflammation-induced IgA⁺ cells dismantle anti-liver cancer immunity. Nature, 551(7680):340-345.

[101]ShedlockDJ, ShenH, 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science, 300(5617):337-339.

[102]SiliņaK, SoltermannA, AttarFM, et al., 2018. Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Res, 78(5):‍1308-1320.

[103]SongIH, HeoSH, BangWS, et al., 2017. Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer. Cancer Res Treat, 49(2):399-407.

[104]SuzukiG, SawaH, KobayashiY, et al., 1999. Pertussis toxin-sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. J Immunol, 162(10):5981-5985.

[105]ThommenDS, KoelzerVH, HerzigP, et al., 2018. A transcriptionally and functionally distinct PD-1⁺ CD8⁺ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat Med, 24(7):994-1004.

[106]TranE, RobbinsPF, LuYC, et al., 2016. T-cell transfer therapy targeting mutant KRAS in cancer. N Engl J Med, 375(23):2255-2262.

[107]van de PavertSA, OlivierBJ, GoverseG, et al., 2009. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol, 10(11):1193-1199.

[108]van DijkN, Gil-JimenezA, SilinaK, et al., 2020. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nat Med, 26(12):1839-1844.

[109]Veiga-FernandesH, ColesMC, FosterKE, et al., 2007. Tyrosine kinase receptor RET is a key regulator of Peyer’s Patch organogenesis. Nature, 446(7135):547-551.

[110]WeinsteinAM, ChenL, BrzanaEA, et al., 2017. Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment. OncoImmunology, 6(6):e1322238.

[111]WorkelHH, LubbersJM, ArnoldR, et al., 2019. A transcriptionally distinct CXCL13⁺CD103⁺CD8⁺ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer. Cancer Immunol Res, 7(5):784-796.

[112]WoutersMCA, NelsonBH, 2018. Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer. Clin Cancer Res, 24(24):6125-6135.

[113]WuSZ, RodenDL, WangCF, et al., 2020. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO J, 39(19):e104063.

[114]WykesM, PomboA, JenkinsC, et al., 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol, 161(3):1313-1319.

[115]YangSC, BatraRK, HillingerS, et al., 2006. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res, 66(6):3205-3213.

[116]YehCH, FinneyJ, OkadaT, et al., 2022. Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5hiPD-1hi T follicular helper cells. Immunity, 55(2):272-289.e7.

[117]YoshidaH, NaitoA, InoueJ, et al., 2002. Different cytokines induce surface lymphotoxin-αβ on IL-7 receptor-α cells that differentially engender lymph nodes and Peyer’s patches. Immunity, 17(6):823-833.